SIGA Technologies Inc SIGA

SIGA reports $38 million in product revenues, driven by US stockpile deliveries and international growth, while navigating slower-than-expected US procurement timelines.

$37 Million of TPOXX Sales Generated in the Second QuarterCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2026. “In the second quarter, we delivered approximately $37 million of TPOXX to three customers: $24 million of IV TPOXX to the U.S. strategic national stockpile and $13 million

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 6, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at http://www.siga.com in

In late June 2026, SIGA Technologies was removed from several Russell growth benchmarks but added to the Russell 2000 Value-Defensive and Defensive indexes, while also filing a US$28.08 million shelf registration for 6,500,000 common shares tied to an ESOP offering. This combination of index reclassification and potential equity issuance highlights a shift in how the market categorizes SIGA’s risk profile and investor base. We’ll now examine how SIGA’s move into defensive indexes shapes its...

In the last week, the market has been flat, but over the past 12 months, it has risen by 27%, with earnings forecasted to grow by 17% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for growth at lower price points when backed by strong balance sheets and solid fundamentals. In this article, we explore several compelling penny stocks that stand out as hidden gems in today's market landscape.

SIGA Technologies, Inc. has released its first-quarter 2026 results, reporting revenue of US$6.24 million versus US$7.04 million a year earlier and a net loss of US$3.45 million compared with US$0.41 million previously. The widening loss per share from continuing operations, rising to US$0.05 from US$0.01, suggests higher pressure on profitability relative to last year. Next, we examine how SIGA’s weaker first-quarter revenue and sharply higher net loss shape the company’s investment...

The market for SIGA Technologies, Inc.'s ( NASDAQ:SIGA ) shares didn't move much after it posted weak earnings...

The United States market has shown robust growth, climbing 3.2% in the last week and up 31% over the past year, with earnings expected to grow annually by 16%. In this context of strong market performance, identifying stocks with solid financial foundations is crucial for investors looking to capitalize on potential gains. While the term "penny stocks" might seem outdated, these often-overlooked smaller or newer companies can offer unique opportunities for growth when supported by strong...

Over the last 7 days, the United States market has risen 3.2%, with a notable climb of 31% over the past year and earnings forecasted to grow by 16% annually. In such a robust market environment, identifying stocks that combine solid financials with growth potential becomes crucial for investors. Penny stocks, although an outdated term, remain relevant as they often represent smaller or newer companies that can offer unique opportunities for significant returns when backed by strong...

Moby summary of SIGA Technologies, Inc.'s Q1 2026 earnings call

On Track to Deliver $13 Million of Oral TPOXX to an International Customer in Second QuarterExpect to Deliver $26 Million of IV TPOXX to the U.S. Government Strategic National Stockpile by End of the Third Quarter Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2026. “Consistent with our lon

Over the last 7 days, the United States market has risen 3.2%, and over the past year, it has climbed an impressive 31%, with earnings forecasted to grow by 16% annually. In such a robust market environment, identifying stocks with strong financials can be key to capturing growth potential. Although the term "penny stocks" might seem outdated, these investments in smaller or newer companies continue to offer intriguing opportunities for those seeking affordability and potential growth.